Dr. Lohmer has been with Nuventra for 5+ years and has experience in all stages of development, with specific interest in concentration-QT analysis and pediatric study plans. Dr. Lohmer has also worked on 18+ approved drugs, NDAs, INDs, a variety of other regulatory submissions, protocols, PK analyses, and population PK analyses.
Education